Quantifying exosomes
How can we quantify the number of exosomes we have and their potency?
How can we quantify the number of exosomes we have and their potency?
Dr. Ed Park of Recharge Biomedical explains how exosomes are made and validated. Dr. Duncan Ross helps explain data that the Kimera Labs team found suggesting large variance in exosome purity and potency between brands.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness